Header graphic for print
The Healthcare Investor Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses

Tag Archives: aco

CMS Announces ESRD Comprensive Care Initiative

Posted in Healthcare Services Investing

The Centers of Medicare & Medicaid Services (CMS) has consistently stated that it does not anticipate approving specialty accountable care organizations.  Thus it is no surprise that CMS has been reluctant to call the new ESRD Seamless Care Organization (ESCO) a "renal ACO" or "renal accountable care organization" and in many ways the new program does differ from the ACO… Continue Reading

ACOs Working Out Initial Difficulties

Posted in Life Sciences Investing

Apparently some early participants in the accountable care organization (ACO) program are experiencing problems accessing crucial CMS (Centers for Medicare and Medicaid Services) data. The acting administrator of CMS has reported to ACO supervisors and others at a conference last week in D.C. that the agency is attempting to streamline access to Medicare enrollees’ data…. Continue Reading

Help is Out There for Providers Interested in Accountable Care Organizations

Posted in Healthcare Services Investing

We have descrived in prior posts the opportunities available through Accountable Care Organizations.   ACOs are intended to provide physicians and medical centers financial incentives to continue offering high-quality medical services to their Medicare patients while keeping costs at an acceptable level through a variety of mechanisms that reward providers for keeping their patient population healthy.  It remains to… Continue Reading

Investment Opportunities in ACOs

Posted in Healthcare Services Investing

Accountable Care Organizations (ACOs) have become a catchphrase within today’s healthcare industry. As we have discussed in prior posts, ACOs are intended to be a vehicle for providing physicians and medical centers financial incentives to continue offering high-quality medical services to their Medicare patients while keeping costs at an acceptable level. Currently, Medicare habitually reimburses… Continue Reading

Long-Awaited Proposed Rules re Shared Savings Program & ACOs Released By CMS, IRS, DOJ & FTC

Posted in Healthcare Services Investing, Industry Events and Announcements

Yesterday, CMS released the much anticipated proposed regulations regarding the Shared Savings Program contemplated in Section 3022 of the healthcare reform law, PPACA.  The 429-page set of regulations is expected to provide greater clarity re CMS’s implementation of HHS’s authority to contract with Accountable Care Organizations (ACOs) under shared savings or other payment arrangements.  The proposed rule provides for a 60… Continue Reading

Will Ancillary Businesses Servicing Emerging ACOs Provide New Investment Opportunities?

Posted in Healthcare Services Investing, Life Sciences Investing

 With ACOs as such a hot topic right now, and the variety of forms these organizations can take, healthcare investors can examine not only opportunities in ACOs themselves but in healthcare related businesses that will service or be affiliated with ACOs. A fundamental tenant of the ACO model is investment in infrastructure aimed at both cost-efficient… Continue Reading

Understanding Accountable Care Organizations (ACOs) and What They Mean to the Healthcare Investor

Posted in Healthcare Services Investing, Life Sciences Investing

  With the authorization of Accountable Care Organizations (ACOs) in the healthcare reform law (PPACA), there has been a tremendous amount of industry attention on understanding ACOs and the opportunities and challenges they present. With ACOs as such a hot topic and the variety of forms these organizations can take, healthcare investors can examine not only… Continue Reading

Key Issues re Investment in the Dialysis Industry

Posted in Healthcare Services Investing, Industry Events and Announcements

On Wednesday, March 12th, McGuireWoods hosted our 8th Annual Business & Legal Issues in Dialysis & Nephrology Symposium. Leaders from various perspectives in the industry provided presentations and lead discussions on a wide array of topics, including the effects of the Patient Protection and Affordable Care Act (the PPACA, commonly referred to as the Health Care… Continue Reading